José Ignacio López Villalba-rekin lankidetzan egindako argitalpenak (11)

2021

  1. The role of epigenetics in the progression of clear cell renal cell carcinoma and the basis for future epigenetic treatments

    Cancers, Vol. 13, Núm. 9

2017

  1. A DNA hypermethylation profile reveals new potential biomarkers for the evaluation of prognosis in urothelial bladder cancer

    APMIS, Vol. 125, Núm. 9, pp. 787-796

2016

  1. A DNA Hypermethylation Profile Independently Predicts Biochemical Recurrence Following Radical Prostatectomy

    Urologia Internationalis, Vol. 97, Núm. 1, pp. 16-25

  2. DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects

    Molecular Diagnosis and Therapy, Vol. 20, Núm. 6, pp. 531-549

  3. Development of Castration Resistant Prostate Cancer can be Predicted by a DNA Hypermethylation Profile

    Journal of Urology, Vol. 195, Núm. 3, pp. 619-626

  4. Survival predictors in patients with prostate adenocarcinoma with hormonal blockade

    Pathology Research and Practice, Vol. 212, Núm. 10, pp. 899-903

2014

  1. A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosis

    Prostate, Vol. 74, Núm. 12, pp. 1171-1182

  2. DNA repair genes and prognosis in sporadic forms of urothelial carcinoma of the upper urinary tract

    Actas Urologicas Espanolas, Vol. 38, Núm. 9, pp. 600-607

  3. Prostate anatomy in motheaten viable (mev) mice with mutations in the protein tyrosine phosphatase SHP-1

    Actas Urologicas Espanolas, Vol. 38, Núm. 7, pp. 438-444

2004

  1. Fosfotirosina fosfatasa SHP-1, somatostatina y cáncer de próstata

    Actas Urologicas Espanolas, Vol. 28, Núm. 4, pp. 269-285

2002

  1. Autocrine regulation of human prostate carcinoma cell proliferation by somatostatin through the modulation of the SH2 domain containing protein tyrosine phosphatase (SHP)-1

    Journal of Clinical Endocrinology and Metabolism, Vol. 87, Núm. 2, pp. 915-926